US Patent 11161890 IL-15-based fusions to IL-7 and IL-21
Patent 11161890 was granted and assigned to Altor BioScience on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+182 characters)
Article
Patent abstract
The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-7 or IL-21.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Hing C. Wong0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111618900
Date of Patent
November 2, 2021
0Patent Application Number
201808280
Date Filed
August 28, 2018
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11161890 IL-15-based fusions to IL-7 and IL-21
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11161890
Date of patent
November 2, 2021
Patent application number
20180828
Date Filed
August 28, 2018
Find more entities like US Patent 11161890 IL-15-based fusions to IL-7 and IL-21
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
